Plunkett Research Online: NovaBay Pharmaceuticals Inc

NOVABAY PHARMACEUTICALS INC (NBY:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

NovaBay Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments. Its proprietary Aganocide compounds are sy.....



NovaBay Pharmaceuticals Inc
Ticker: NBY
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 510 899-8800
Fax: 510 225-0371
Address: 2000 Powell Street
Suite 1150
Emeryville, CA 94608 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Mark SieczkarekCEO/Chairman of the Board/Director
John McGovernCFO/Treasurer
See More
NovaBay Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments. Its proprietary Aganocide compounds are sy.....See More See More

Auditor: OUM & Co. LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: